Leaderboards/Pharmacological Effects and Toxicity Studies

Pharmacological Effects and Toxicity Studies

Last updated July 15, 2026

Rising Stars

Fresh ink, massive impact

Researchers

1
Haru Hirai
Tokyo University of the Arts
2
Viveka K. Kulkarni
Queen's University
3
Håkon Magne Vegrim
Haukeland University Hospital
4
Abdullah Yılgör
Van Yüzüncü Yıl Üniversitesi
5
Chrysiida Baltira
The Netherlands Cancer Institute
6
Tetyana I. Levchenko
Queen's University
7
Jeffrey Khong
Center For Reconstructive Urethral Surgery
8
Shawn Pei Feng Tan
Manchester Academic Health Science Centre
9
Yutong Fu
Sichuan University
10
Renee W. Y. Man
Nagoya University

Papers

1
Determination of oxidative stress level and some antioxidant activities in refractory epilepsy patients
Scientific Reports|2024
69 cit.
2
The impact of ATP-binding cassette transporters in the diseased brain: Context matters
Cell Reports Medicine|2024
54 cit.
3
Impact of Ligand Structure on Biological Activity and Photophysical Properties of NHC-Protected Au<sub>13</sub> Nanoclusters
Journal of the American Chemical Society|2025
32 cit.
4
High‐dose folic acid use and cancer risk in women who have given birth: A register‐based cohort study
Epilepsia|2024
17 cit.
5
Publication in Molecular Pharmaceutics (2024) [12 citations, W4401733994]
Molecular Pharmaceutics|2024
12 cit.
6
Introducing Iodide Ligands on IrAu<sub>12</sub> Cluster Enhances Phosphorescence Efficiency and Photoredox Activity
ChemElectroChem|2024
9 cit.
7
Publication in Epilepsia (2024) [7 citations, W4393341871]
Epilepsia|2024
7 cit.
8
Publication in CPT Pharmacometrics & Systems Pharmacology (2025) [6 citations, W4408161741]
CPT Pharmacometrics & Systems Pharmacology|2025
6 cit.
9
Publication in Drug Metabolism and Pharmacokinetics (2025) [W4410993707]
Drug Metabolism and Pharmacokinetics|2025
0 cit.
10
Publication in Biological Rhythm Research (2025) [W4415460697]
Biological Rhythm Research|2025
0 cit.

Emerging Leaders

Drafting the new consensus

Researchers

1
Amy Price
Royal Free London NHS Foundation Trust
2
Lisa A. Gurski
National Comprehensive Cancer Network
3
Morteza Zarifi-Oskoie
Unknown
4
WC Winkelmayer
Unknown
5
Yangjian Quan
Hong Kong University of Science and Technology
6
Alexander M. Spokoyny
California NanoSystems Institute
7
Masakazu Nambo
Nagoya University
8
Xinxin Ci
Jilin University
9
Cenk Varlık
Sağlık Bilimleri Üniversitesi
10
H. Birgül Elbozan
Unknown

Papers

1
Rectal Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network|2022
819 cit.
2
NCCN Guidelines® Insights: Bladder Cancer, Version 2.2022
Journal of the National Comprehensive Cancer Network|2022
302 cit.
3
Bladder Cancer, Version 3.2024
Journal of the National Comprehensive Cancer Network|2024
236 cit.
4
NCCN Guidelines® Insights: Rectal Cancer, Version 3.2024
Journal of the National Comprehensive Cancer Network|2024
215 cit.
5
NCCN Guidelines® Insights: Kidney Cancer, Version 2.2024
Journal of the National Comprehensive Cancer Network|2024
166 cit.
6
Desulfonylative Transformations of Sulfones by Transition-Metal Catalysis, Photocatalysis, and Organocatalysis
ACS Catalysis|2022
120 cit.
7
Desulfonylative Coupling of Alkylsulfones with <i>gem-</i>Difluoroalkenes by Visible-Light Photoredox Catalysis
ACS Catalysis|2022
41 cit.
8
Daphnetin ameliorates PM2.5-induced airway inflammation by inhibiting NLRP3 inflammasome-mediated pyroptosis in CS-exposed mice
Biomedicine & Pharmacotherapy|2023
41 cit.
9
Metal-organic framework boosts heterogeneous electron donor–acceptor catalysis
Nature Communications|2023
41 cit.
10
Ultrafast Au(III)-Mediated Arylation of Cysteine
Journal of the American Chemical Society|2024
37 cit.

Current Senior Leaders

Wrote the book, still writing it

Researchers

1
Yuichi Sugiyama
ShanghaiTech University
2
Sameer M. Zuberi
Carol Davila University of Medicine and Pharmacy
3
Alfred H. Schinkel
Oncode Institute
4
Jacqueline A. French
Epilepsy Foundation
5
Wolfgang Löscher
Medizinische Hochschule Hannover
6
Martin J. Brodie
Western Infirmary
7
Emilio Perucca
The University of Melbourne
8
Leslie Z. Benet
University of California, San Francisco
9
Jerome Engel
Allen Institute for Brain Science
10
Josemir W. Sander
National Hospital for Neurology and Neurosurgery

Papers

1
Early Identification of Refractory Epilepsy
New England Journal of Medicine|2000
5.2k cit.
2
<scp>ILAE</scp> classification of the epilepsies: Position paper of the <scp>ILAE</scp> Commission for Classification and Terminology
Epilepsia|2017
4.9k cit.
3
Definition of drug resistant epilepsy: Consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies
Epilepsia|2009
4.7k cit.
4
Epileptic Seizures and Epilepsy: Definitions Proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE)
Epilepsia|2005
3.6k cit.
5
Operational classification of seizure types by the International League Against Epilepsy: Position Paper of the ILAE Commission for Classification and Terminology
Epilepsia|2017
3.4k cit.
6
Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs
Cell|1994
2.3k cit.
7
Outcome with respect to epileptic seizures.
Medical Entomology and Zoology|1993
2k cit.
8
Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview
Advanced Drug Delivery Reviews|2003
1.4k cit.
9
P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs.
Journal of Clinical Investigation|1996
1.3k cit.
10
Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview
Advanced Drug Delivery Reviews|2012
1.2k cit.

Reagents for Pharmacological Effects and Toxicity Studies

Citation-validated products used in this field

🔥 Trending

Gaining adoption fast

⭐ Top Rated

Best all-around

Cell Signaling TechnologyEvidence 65

BATF (F2L7C) Rabbit Monoclonal Antibody

#30889$178,415
View Evidence →
Cell Signaling Technology

IkappaB zeta Antibody

#9244$317
View Evidence →
Cell Signaling Technology

MYO1D (E6T6Q) Rabbit Monoclonal Antibody

#90307$161,351
View Evidence →

🌟 All-Time

Most validated

Cell Signaling TechnologyEvidence 65

GATA-4 (D3A3M) Rabbit Monoclonal Antibody (SignalFlex™ Alexa Fluor® 350 Conjugate)

Cited in 14 papers
#31948$458
View Evidence →
Cell Signaling Technology

Kindlin-1 (D1K4C) Rabbit Monoclonal Antibody

Cited in 9 papers
#36734$160,351
View Evidence →
Cell Signaling TechnologyEvidence 66

HA-Tag (C29F4) Mouse Chimeric Monoclonal Antibody

Cited in 5 papers
#45688$161,376
View Evidence →